Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × Olanzapine × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Head & Neck 1 Genitourinary 1

Conditions

Lung Neoplasms 2 Vomiting 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 3 Aprepitant 2 netupitant, palosentron drug combination 1 netupitant 1 fosaprepitant 1 casopitant 1 Yoga 1 Therapeutics 1 Radiotherapy 1 Palonosetron 1 Ondansetron 1 Olanzapine 1 Exercise 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03571126 2021-07-13

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Zunyi Medical College

Phase 4 Unknown

Lung Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡